Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion

Background and aims: Lamivudine induces favourable virological and biochemical responses but post-treatment relapses are frequent, even in patients with hepatitis B e antigen (HBeAg) loss or seroconversion. The aim of this study was to determine whether extended lamivudine therapy for up to 12 month...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, H C, Suh, D J, Ryu, S H, Kim, H, Shin, J W, Lim, Y-S, Chung, Y-H, Lee, Y S
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Copyright 2003 by Gut 2003
Gaiak:
Liver
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773893/
https://ncbi.nlm.nih.gov/pubmed/14633962
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak